
Fidji Simo, OpenAI's president of applications since May 2025, stepped down from her full-time role on Thursday to transition to part-time advisory work while recovering from a chronic illness that required medical leave three months ago. The move reflects her decision to prioritize health recovery over a demanding executive position, and follows several other senior departures from OpenAI in 2025.
Summaries like this, in your inbox every morning.
Sign up free →What happened
Fidji Simo, who was appointed OpenAI's president of applications in May 2025, stepped down from her full-time role on Thursday and transitioned to a part-time advisory position. She took medical leave three months ago after a severe exacerbation of a chronic illness she has lived with for seven years.
Why it matters
Simo's departure marks another senior leadership shift at OpenAI this year, following the departures of the company's head of private equity (who left for Google) and a sales leader (who departed for Thrive Capital). Her step back underscores the tension between ambitious career roles and health priorities, especially for executives managing long-term medical conditions.
What to watch
Simo remains committed to working toward disease cures through OpenAI and her involvement with Chronicle BioAI and CODA Research. During her absence, Greg Brockman oversaw product, Brad Lightcap transitioned to special projects, and Denise Dresser assumed most of Lightcap's responsibilities.
Fidji Simo's transition from full-time president of applications to part-time advisor represents a significant leadership adjustment at OpenAI, occurring less than two years after her appointment to the newly created role in May 2025. Her medical leave in April and subsequent step-down highlight the extended nature of her chronic illness recovery—a condition she has managed for seven years but which required a severe exacerbation to force a change in her work arrangement. Simo's candid reflection that she "failed to make this decision many times before" suggests the organizational and personal pressures that can delay necessary health-focused choices, even in a company with resources to support medical leave (she referenced Meta's earlier offer of a full year off).
The departure occurs within a broader pattern of senior attrition at OpenAI in 2025, including the departure of the head of private equity to Google and a sales leader to Thrive Capital. During Simo's absence, the company reorganized leadership responsibilities, with Brockman, Lightcap, and Dresser assuming new or expanded roles. Simo's continued involvement in disease-cure initiatives through Chronicle BioAI and CODA Research suggests that her commitment to health-related work persists even as her executive responsibilities scale back, aligning her stepped role with her stated priorities.
No discussion yet for this article
Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.
Get Started FreeFree · takes 30 seconds · unsubscribe anytime
1 minute a day. The AI essentials.
200+ sources · Email / LINE / Slack